Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
in TCC, GSTP1 should be considered as a potential therapeutic target This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
They promised us well in excess of 8 year trials was the next thing we needed to study
Community sources describe blends as more convenient (one vial, one injection) and often lower cost per cycle
Ongoing evaluation: Document response at each milestone and adjust with practitioner guidance before extending cycles
US$ 24.09
US$ 21.95
US$ 27.12
US$ 24.07
US$ 23.13
US$ 29.61
US$ 27.35
US$ 21.23
US$ 22.53
